IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 124 filers reported holding IMMUNITYBIO INC in Q2 2021. The put-call ratio across all filers is 3.20 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $260,505 | -34.0% | 41,219 | -43.9% | 0.00% | – |
Q1 2024 | $394,513 | +3.0% | 73,466 | -3.7% | 0.00% | – |
Q4 2023 | $382,946 | +197.3% | 76,284 | +0.1% | 0.00% | – |
Q3 2023 | $128,812 | -37.4% | 76,220 | +2.9% | 0.00% | – |
Q2 2023 | $205,870 | +74.5% | 74,054 | +14.3% | 0.00% | – |
Q1 2023 | $117,951 | -66.3% | 64,808 | -6.0% | 0.00% | – |
Q4 2022 | $349,688 | +22.7% | 68,972 | +20.6% | 0.00% | – |
Q3 2022 | $285,000 | +38.3% | 57,171 | +3.0% | 0.00% | – |
Q2 2022 | $206,000 | -19.5% | 55,493 | +21.8% | 0.00% | – |
Q1 2022 | $256,000 | -10.2% | 45,568 | -2.7% | 0.00% | – |
Q4 2021 | $285,000 | +35.1% | 46,816 | +116.2% | 0.00% | – |
Q3 2021 | $211,000 | -41.2% | 21,653 | -13.9% | 0.00% | – |
Q2 2021 | $359,000 | -37.0% | 25,163 | +4.9% | 0.00% | – |
Q1 2021 | $570,000 | – | 23,990 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALLEN HOLDING INC /NY | 687,571 | $3,857,000 | 0.50% |
ORACLE INVESTMENT MANAGEMENT INC | 400,013 | $2,244,000 | 0.44% |
HARBOURVEST PARTNERS LLC | 335,709 | $1,883,000 | 0.38% |
Winning Points Advisors, LLC | 60,126 | $339,000 | 0.26% |
MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $541,000 | 0.19% |
SHEETS SMITH WEALTH MANAGEMENT | 203,876 | $1,144,000 | 0.16% |
Delphia (USA) Inc. | 25,504 | $143,000 | 0.11% |
Clearwater Capital Advisors, LLC | 147,891 | $830,000 | 0.10% |
Corton Capital Inc. | 36,843 | $207,000 | 0.09% |
Virtus ETF Advisers LLC | 27,343 | $153,000 | 0.07% |